AMPE - Ampio Pharmaceuticals, Inc.

NYSE American - Nasdaq Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue---
Cost of Revenue---
Gross Profit---
Operating Expenses
Research Development10,546.28715,111.68622,490.578
Selling General and Administrative6,536.0679,055.8858,957.441
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-17,082.354-24,167.571-31,448.019
Income from Continuing Operations
Total Other Income/Expenses Net-1,037.92259.853142.984
Earnings Before Interest and Taxes-19,163.629-24,107.718-31,305.035
Interest Expense---
Income Before Tax-19,163.629-24,107.718-31,305.035
Income Tax Expense---
Minority Interest-927.83-659.747
Net Income From Continuing Ops-19,163.629-24,107.718-31,305.035
Non-recurring Events
Discontinued Operations--9,606.199-7,743.737
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-19,163.629-32,010.242-38,125.415
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-19,163.629-32,010.242-38,125.415